Disentangling Mitochondria in Alzheimer's Disease

Area of Science:

• Neuroscience
• Gerontology
• Biochemistry

Background:

• Alzheimer's disease (AD) is a leading cause of dementia in aging populations, posing significant societal and economic challenges.
• Current treatments for AD are primarily symptomatic, highlighting the need for disease-modifying therapies.
• The complex etiology of AD involves mitochondrial dysfunction, oxidative stress, inflammation, and metabolic abnormalities.

Purpose of the Study:

• To review the causative factors contributing to Alzheimer's disease.
• To discuss potential therapeutic strategies for treating AD, focusing on underlying pathological mechanisms.
• To evaluate the current evidence for interventions targeting mitochondrial health and oxidative stress.

Main Methods:

• Literature review of studies investigating Alzheimer's disease pathology and therapeutics.
• Analysis of research on mitochondrial dysfunction, oxidative stress, and metabolic abnormalities in AD.
• Examination of clinical trial data for mitochondria-targeted antioxidants and lifestyle interventions.

Main Results:

• Mitochondrial dysfunction and oxidative stress are key contributors to AD neuropathology.
• Interventions like diet, exercise, and mitochondria-targeted antioxidants show potential in reducing amyloid-beta (Aβ) plaques and improving cognitive function.
• Numerous mitochondria-targeted antioxidants are under investigation for AD treatment.

Conclusions:

• Restoring mitochondrial bioenergetics and preventing oxidative stress are promising therapeutic avenues for AD.
• Lifestyle interventions, including diet and exercise, may help ameliorate AD symptoms and pathology.
• Larger, well-designed clinical studies are essential to validate the efficacy of emerging AD therapeutics.